Common questions about Diclegis (FAQ)
Q: How quickly can someone expect Diclegis to start working?
Studies on the medication’s pharmacokinetics—how the body processes the drug—indicate that peak blood concentrations of the doxylamine ingredient are generally reached about 3.5 hours after a dose is taken on an empty stomach. Because of the delayed-release design of the tablet, taking it with food may further delay this onset of action.
Q: Can Diclegis be used during all trimesters of pregnancy?
The clinical trials that established the medication's efficacy were primarily conducted in pregnant women between 7 and 14 weeks of gestation, which is the period when Nausea and Vomiting of Pregnancy (NVP) is most common. Official documents state that the need for continued use is recommended to be reassessed by a healthcare provider as the pregnancy progresses.
Q: Can Diclegis be taken with other common pregnancy medications?
Official regulatory documents warn against combining Diclegis with medicines that cause drowsiness, which are classified as Central Nervous System (CNS) depressants. Use is also prohibited with MAO inhibitors. Consultation with a healthcare provider is necessary for a comprehensive review of all current and planned medications.
Q: Are there any specific foods or drinks that should be avoided with Diclegis?
Official documents state the medication is taken on an empty stomach to prevent food from delaying the onset of action and reducing absorption. Additionally, the label recommends avoiding concurrent use of alcohol due to the significant risk of compounding the drowsiness effect from the medication.
Q: How is Diclegis different from anti-nausea medicines given in the hospital?
Diclegis is a fixed-dose combination product containing doxylamine (an antihistamine) and pyridoxine (Vitamin B6) in a delayed-release tablet specifically approved for the treatment of NVP in women who don't respond to conservative management.
Q: What does the safety classification of Diclegis mean in simple terms?
Historically, Diclegis was one of the few medications assigned the FDA's Pregnancy Category A rating, which was used to indicate that controlled studies in women had not demonstrated an increased risk of harm to the fetus. The FDA has since moved to a newer rating system, but the original categorization reflects the established safety profile.
Q: What is the typical duration of treatment with Diclegis?
Efficacy for the medication was demonstrated in short-term clinical trials lasting 14 days. Regulatory documents state that the need for continued use is recommended to be reassessed by a healthcare provider as the pregnancy progresses, rather than setting a fixed time limit.
Q: Is Diclegis known to interact with common prenatal vitamins?
Official labeling advises that caution is necessary regarding the total daily intake of Pyridoxine (Vitamin B6) from both the medication and any other supplements, including prenatal vitamins. Reviewing the full content of any multivitamin with a healthcare professional is necessary for determining total intake.
Q: Does using Diclegis affect the results of any common blood tests?
Regulatory information only specifies that the doxylamine component of the drug may cause false positive results for substances like opiates and PCP in certain urine drug screens. No official warnings are listed regarding interference with common blood tests.
Q: Why do some people refer to this medicine by its original name?
The specific combination of doxylamine and pyridoxine was previously sold under the brand name Bendectin decades ago to treat morning sickness. As a result, some people who were aware of the historical product may still refer to it by that original name.
Q: Is Diclegis considered a last resort option for morning sickness?
Official indications state that the medication is for women whose NVP symptoms do not respond to conservative management. This confirms it is intended as a treatment option after initial non-pharmacological methods have been tried and failed.
Q: Is there a generic version of Diclegis available?
Yes, the FDA has approved generic versions of the Doxylamine Succinate and Pyridoxine Hydrochloride delayed-release tablets. These generic equivalents are chemically identical and are subject to the same strict regulatory standards as the brand-name product.
Q: Does Diclegis contain any common allergens like lactose or gluten?
Official European product documents mention that Diclegis contains the coloring agent Allura Red AC (E129), which may cause allergic reactions in sensitive individuals. Contraindications include hypersensitivity to any of the product's active or inactive ingredients.
Q: What are the ingredients besides the active drug components?
The tablets contain a full list of inactive ingredients, known as excipients, in addition to the active ingredients (doxylamine succinate and pyridoxine hydrochloride). This complete list is provided in the prescribing information and is available for consultation for specific content.
Q: What is the half-life (duration in the body) of Diclegis?
Pharmacokinetic data from the FDA indicate that the terminal elimination half-life—the time it takes for half the drug to be eliminated from the body—is about 12.5 hours for doxylamine and 0.5 hours for pyridoxine.
Q: Is it correct that Diclegis is the only FDA-approved medication for morning sickness?
Yes, Diclegis is the only prescription medication currently FDA-approved specifically for the treatment of Nausea and Vomiting of Pregnancy (NVP) in women who do not respond to conservative management.
Q: Is there a higher risk of side effects with higher doses (non-directive question)?
The prescribed regimen allows for dose escalation up to the maximum recommended daily limit to achieve symptom control. While regulatory documents describe this titration process, drowsiness remains the most common reported side effect.
Q: What are the general expectations if Diclegis does not provide sufficient relief?
If symptoms are not controlled, the dose may be escalated according to the prescribed regimen up to the maximum dose. If symptoms remain severe, consultation with a healthcare provider is necessary, as the drug has not been studied in the most severe form of NVP, known as hyperemesis gravidarum.
Q: Has Diclegis been studied in women with severe hyperemesis gravidarum?
No, official regulatory labeling states that Diclegis has not been studied in women with hyperemesis gravidarum, which is the most severe and debilitating form of Nausea and Vomiting of Pregnancy.
